325 related articles for article (PubMed ID: 31367993)
1. Treatment of Pruritus Secondary to Liver Disease.
Düll MM; Kremer AE
Curr Gastroenterol Rep; 2019 Jul; 21(9):48. PubMed ID: 31367993
[TBL] [Abstract][Full Text] [Related]
2. Management of Chronic Hepatic Itch.
Düll MM; Kremer AE
Dermatol Clin; 2018 Jul; 36(3):293-300. PubMed ID: 29929600
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
[TBL] [Abstract][Full Text] [Related]
4. Advances in pathogenesis and management of pruritus in cholestasis.
Kremer AE; Bolier R; van Dijk R; Oude Elferink RP; Beuers U
Dig Dis; 2014; 32(5):637-45. PubMed ID: 25034299
[TBL] [Abstract][Full Text] [Related]
5. Cholestatic Itch Management.
Mittal A
Curr Probl Dermatol; 2016; 50():142-8. PubMed ID: 27578083
[TBL] [Abstract][Full Text] [Related]
6. Endogenous Opioid Levels Do Not Correlate With Itch Intensity and Therapeutic Interventions in Hepatic Pruritus.
Düll MM; Wolf K; Vetter M; Dietrich P; Neurath MF; Kremer AE
Front Med (Lausanne); 2021; 8():641163. PubMed ID: 33937284
[No Abstract] [Full Text] [Related]
7. Pathophysiology and current management of pruritus in liver disease.
Kremer AE; Oude Elferink RP; Beuers U
Clin Res Hepatol Gastroenterol; 2011 Feb; 35(2):89-97. PubMed ID: 21809485
[TBL] [Abstract][Full Text] [Related]
8. Cholestatic pruritus : an update.
De Vloo C; Nevens F
Acta Gastroenterol Belg; 2019; 82(1):75-82. PubMed ID: 30888758
[TBL] [Abstract][Full Text] [Related]
9. Safety considerations for the management of cholestatic itch.
Trivella J; Levy C
Expert Opin Drug Saf; 2021 Aug; 20(8):915-924. PubMed ID: 33836644
[No Abstract] [Full Text] [Related]
10. Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis.
Fujino H; Tanaka M; Imamura M; Morio K; Ono A; Nakahara T; Murakami E; Kawaoka T; Takahashi S; Miki D; Tsuge M; Hiramatsu A; Aikata H; Hayes CN; Chayama K
BMC Gastroenterol; 2019 Oct; 19(1):169. PubMed ID: 31651244
[TBL] [Abstract][Full Text] [Related]
11. Cholestatic pruritus: Emerging mechanisms and therapeutics.
Patel SP; Vasavda C; Ho B; Meixiong J; Dong X; Kwatra SG
J Am Acad Dermatol; 2019 Dec; 81(6):1371-1378. PubMed ID: 31009666
[TBL] [Abstract][Full Text] [Related]
12. [Pruritus in liver disease. Pathogenesis and treatment].
Kremer AE; Maillette de Buy Wenniger L; Oude Elferink RP; Beuers U
Ned Tijdschr Geneeskd; 2011; 155(52):A4045. PubMed ID: 22217242
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
Kremer AE; Martens JJ; Kulik W; Ruëff F; Kuiper EM; van Buuren HR; van Erpecum KJ; Kondrackiene J; Prieto J; Rust C; Geenes VL; Williamson C; Moolenaar WH; Beuers U; Oude Elferink RP
Gastroenterology; 2010 Sep; 139(3):1008-18, 1018.e1. PubMed ID: 20546739
[TBL] [Abstract][Full Text] [Related]
14. Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus.
Hegade VS; Pechlivanis A; McDonald JAK; Rees D; Corrigan M; Hirschfield GM; Taylor-Robinson SD; Holmes E; Marchesi JR; Kendrick S; Jones DE
Liver Int; 2019 May; 39(5):967-975. PubMed ID: 30735608
[TBL] [Abstract][Full Text] [Related]
15. Pruritus secondary to primary biliary cholangitis: a review of the pathophysiology and management with phototherapy.
Hussain AB; Samuel R; Hegade VS; Jones DE; Reynolds NJ
Br J Dermatol; 2019 Dec; 181(6):1138-1145. PubMed ID: 30920648
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of pruritus in cholestasis: understanding and treating the itch.
Beuers U; Wolters F; Oude Elferink RPJ
Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):26-36. PubMed ID: 36307649
[TBL] [Abstract][Full Text] [Related]
17. Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments.
Vander Does A; Levy C; Yosipovitch G
Am J Clin Dermatol; 2022 Sep; 23(5):647-659. PubMed ID: 35900649
[TBL] [Abstract][Full Text] [Related]
18. Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders.
Kremer AE; Gonzales E; Schaap FG; Oude Elferink RP; Jacquemin E; Beuers U
J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):530-5. PubMed ID: 26628447
[TBL] [Abstract][Full Text] [Related]
19. Pruritus in cholestasis: facts and fiction.
Beuers U; Kremer AE; Bolier R; Elferink RP
Hepatology; 2014 Jul; 60(1):399-407. PubMed ID: 24807046
[TBL] [Abstract][Full Text] [Related]
20. [Management of pruritus in patients with cholestatic liver disease].
Kremer AE; Kraus MR
MMW Fortschr Med; 2016 Jun; 158(12):64-7. PubMed ID: 27324009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
